- Home
- GPC vs HUMAW Comparison
GPC vs HUMAW Comparison
Compare GPC & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPC
- HUMAW
- Stock Information
- Founded
- GPC 1928
- HUMAW 2004
- Country
- GPC United States
- HUMAW United States
- Employees
- GPC N/A
- HUMAW 185
- Industry
- GPC Automotive Aftermarket
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- GPC Consumer Discretionary
- HUMAW Health Care
- Exchange
- GPC Nasdaq
- HUMAW Nasdaq
- Market Cap
- GPC N/A
- HUMAW N/A
- IPO Year
- GPC N/A
- HUMAW N/A
- Fundamental
- Price
- GPC $117.42
- HUMAW $0.30
- Analyst Decision
- GPC Buy
- HUMAW
- Analyst Count
- GPC 7
- HUMAW 0
- Target Price
- GPC $130.86
- HUMAW N/A
- AVG Volume (30 Days)
- GPC 1.3M
- HUMAW 14.2K
- Earning Date
- GPC 04-22-2025
- HUMAW 03-21-2025
- Dividend Yield
- GPC 3.51%
- HUMAW N/A
- EPS Growth
- GPC N/A
- HUMAW N/A
- EPS
- GPC 6.09
- HUMAW N/A
- Revenue
- GPC $23,569,007,000.00
- HUMAW N/A
- Revenue This Year
- GPC $3.51
- HUMAW N/A
- Revenue Next Year
- GPC $3.77
- HUMAW N/A
- P/E Ratio
- GPC $19.27
- HUMAW N/A
- Revenue Growth
- GPC 1.99
- HUMAW N/A
- 52 Week Low
- GPC $104.01
- HUMAW $1.18
- 52 Week High
- GPC $158.65
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- GPC 50.78
- HUMAW N/A
- Support Level
- GPC $115.68
- HUMAW N/A
- Resistance Level
- GPC $118.69
- HUMAW N/A
- Average True Range (ATR)
- GPC 2.61
- HUMAW 0.00
- MACD
- GPC 0.28
- HUMAW 0.00
- Stochastic Oscillator
- GPC 61.49
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.